Uncategorized
COVID-19 Prolongado
/One pager informativo sobre el COVID Prolongado. Disponible para descargar.
Read more »
Health disparity and COVID-19-A retrospective analysis”: La relación entre las disparidades o desigualdades de salud y casos positivos de COVID-19 es descrita por los autores de este estudio. Establecieron que poblaciones afroamericanas enfrentan desventajas socioeconómicas que pueden llevar al desarrollo de obesidad, diabetes tipo 2 y enfermedades cardiacas. Personas con estas condiciones sufren de un alto riesgo para desarrollar enfermedad severa del COVID-19.
/Abstract Background and aims: According to the World Health Organization (WHO), more than 75.7 million confirmed cases of coronavirus disease 2019 (COVID-19), a global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have been reported so far. Researchers are working relentlessly to find effective solutions to this catastrophe, using genomic sequence-based investigation, immunological analysis, and […]
Read more »
Acute leukemia and SARS-CoV-S infection: clinical characteristics and risk factors for mortality”: Pacientes de leucemia aguda demuestran alta mortalidad a causa de infección del virus causante del COVID-19. Este artículo científico determina los pasos a seguir para evitar mortalidad.
/Abstract Patients with acute leukemia (AL) have a high mortality rate from coronavirus disease 2019 (COVID-19). However, studies including patients with AL and COVID-19 are few. Fifty-one patients with AL and COVID-19 were included in our study. The mortality rate was 17/51 (29.4%). In all cases, death was associated with COVID-19 pneumonia. The major driver […]
Read more »
Cardiovascular considerations of Remdesivir and Favipiravir in the treatment of COVID-19”: Estudio sobre tratamientos de anticuerpos monoclonales, Remdesicir y Favipiravir, para pacientes de COVID-19. En este artículo, se estudian los efectos y beneficios de los tratamientos para pacientes con condiciones cardiovasculares.
/Abstract After the outbreak of COVID-19, many novel drugs have been introduced to improve patients’ condition. Remdesivir and Favipiravir are among the most common drugs used against SARS-CoV-2. Although promising, cardiovascular side effects of these drugs should be considered by physicians and nurses. In this study, we searched databases for assessing the cardiovascular side effects […]
Read more »
Characterization and Outcomes of Hospitalized Children With Coronavirus Disease 2019: A Report From a Multicenter, Viral Infection and Respiratory Illness Universal Study (Coronavirus Disease 2019) Registry”: Resumen de la data obtenida sobre pacientes pediátricos
/Abstract Objectives: Multicenter data on the characteristics and outcomes of children hospitalized with coronavirus disease 2019 are limited. Our objective was to describe the characteristics, ICU admissions, and outcomes among children hospitalized with coronavirus disease 2019 using Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study: Coronavirus Disease 2019 registry. Design: Retrospective study. […]
Read more »
Determinants and dynamics of SARS-CoV-2 infection in a diverse population: 6-month evaluation of a prospective cohort study”: Estudio sobre los factores de riesgo, las respuestas serológicas o de anticuerpos y los síntomas de infección de COVID-19 en una población diversa de pacientes
/Abstract Background: We studied risk factors, antibody responses, and symptoms of SARS-CoV-2 infection in a diverse, ambulatory population. Methods: A prospective cohort (n=831, including 548 hospital-based healthcare workers) previously undiagnosed with SARS-CoV-2 infection was followed for six months with serial testing (SARS-CoV-2 PCR, specific IgG) and surveys. Results: 93 participants (11.2%) tested SARS-CoV-2-positive; 14 (15.1%) were asymptomatic and […]
Read more »